Perspective · 30 Nov 2024
Review articlePublished 11 Jul 2016
Targeting Soluble Epoxide Hydrolase for Temporal Lobe Epilepsy
1Institute of Brain Science, National Yang Ming University, Taipei, Taiwan; 2Laboratory of Neurophysiology, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; 3Brain Research Center, National Yang Ming University, Taipei, Taiwan; 4School of Medicine, National Yang Ming University, Taipei, Taiwan; 5Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan; 6Section of Cerebrovascular Diseases, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan; 7Department of Neurology, the Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Epilepsy is a common brain disorder characterized by a chronic predisposition to generate spontaneous seizures. It remains unknown regarding the mechanisms for epilepsy formation. Prolonged seizures trigger significant neuroinflammatory responses in experimental and human temporal lobe epilepsy, which have been speculated to be mediating the epileptogenesis. Currently, extensive evidence suggests that anti-inflammatory approaches might offer a promising alternative therapeutic strategy especially when antiepileptic medications are ineffective. By diminishing the anti-inflammatory activities of epoxyeicosatrienoic acids (EETs), soluble epoxide hydrolase (sEH) has been considered a potential therapeutic target for epileptic seizures. Here we review evidences concerning the relevance of neuroinflammarion to the pathophysiology of epilepsy, the physiological functions of EETs-sEH metabolism in central nervous system, and the linkage of EET-sEH pathway to neuroinflammation and neuromodulation. Several contemporary studies have contributed to defining the importance of sEH inhibition in modulating inflammatory responses and abnormal hyperexcitability related to epilepsy. Notwithstanding some discrepancies have been noted between different experimental models or between pharmacological inhibition and genetic deletion of sEH, the involvement of sEH in the generation and progression of epilepsy suggests that sEH may be an attractive target for therapeutic intervention.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Neuroimmunology.
Letter · 30 Nov 2024
Understanding the Interactions Between Immune Cells and Neurons: Insights
Case series · 30 Nov 2024
T-Cell Mediated Neuroinflammation in Multiple Sclerosis: A Critical Review
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Neuroimmunology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Yu-Wen Hung”
- BylineArticles whose byline prints “Yung-Yang Lin”
